- Opportunities for CDMOs, sponsors, and suppliers
- Clinical trials: what to expect?
- Impact of the Biosecure Act
- Trends in outsourcing clinical trials – supply chain disruption
Archives: Agenda
Morning refreshments and networking sponsored by Hiro
Applying product launch strategy to clinical trials: A reimagined approach to recruitment and retention (Stream A room onsite)
- Competition for patients in clinical trials is fierce, and putting the trial at the front of mind of PIs, site teams, referral networks, and patients is crucial to win in patient engagement
- A successful recruitment and retention strategy has to reach target HCPs and patients with accelerated precision through an engagement campaign that starts with an evidence-based point of reference, builds confidence in the trial, delivers a resonating call to action, and evolves as clinical insights start flowing in
- A new approach to recruitment and retention takes inspiration from ways of working within Medical and Commercial teams and produces durable outputs that evolve into the essentials of a product launch toolkit, facilitating organizational efficiency
Creating the first protocol design with AI: Shortening protocol design processes to less than 3 months (Stream A room onsite)
- How AI optimizes clinical trial protocols to reduce errors, streamline processes, and enhance data quality
- A Real-world case study of reduced timelines and improved trial outcomes using Biorce’s platform
- Insights into leveraging predictive analytics for trial success
Registration and Refreshments
Chairperson’s opening remarks
Improving clinical supply chain with digital display labelling
- Enhancing real-time data visibility and accuracy
- Streamlining compliance and regulatory adherence
- Boosting flexibility and efficiency in clinical supply management
ROUNDTABLE SESSIONS
During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.
Roundtable 1
Progressing your planning as a small biotech whilst in funding mode
Judi Simonsen, CEO and Co-Founder, MERODZ
Roundtable 2
Selecting and managing sites: key considerations
Catharina Östberg, Head of Site Management Nordics, Bayer
Roundtable 3
Considering sustainability throughout the clinical supply chain: where can we improve?
Kamal Amin, Head of Supply Chain Management, Galderma
Roundtable 4
Integrating AI into clinical operations
Pietro Belligoli, Researcher, Former Roche